These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30194005)

  • 1. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
    Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
    Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Molecular Characterization of Uterine Carcinosarcoma.
    Cherniack AD; Shen H; Walter V; Stewart C; Murray BA; Bowlby R; Hu X; Ling S; Soslow RA; Broaddus RR; Zuna RE; Robertson G; Laird PW; Kucherlapati R; Mills GB; ; Weinstein JN; Zhang J; Akbani R; Levine DA
    Cancer Cell; 2017 Mar; 31(3):411-423. PubMed ID: 28292439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
    Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
    Moukarzel LA; Ferrando L; Da Cruz Paula A; Brown DN; Geyer FC; Pareja F; Piscuoglio S; Papanastasiou AD; Fusco N; Marchiò C; Abu-Rustum NR; Murali R; Brogi E; Wen HY; Norton L; Soslow RA; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    Mol Oncol; 2021 Apr; 15(4):1024-1039. PubMed ID: 33021035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition.
    Cuevas IC; Sahoo SS; Kumar A; Zhang H; Westcott J; Aguilar M; Cortez JD; Sullivan SA; Xing C; Hayes DN; Brekken RA; Bae-Jump VL; Castrillon DH
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25880-25890. PubMed ID: 31772025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; ; Merino MJ; Mutch DG; Goodfellow PJ; Mullikin JC; Bell DW
    Cancer; 2018 Jan; 124(1):65-73. PubMed ID: 28940304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth molecular profiling of the biphasic components of uterine carcinosarcomas.
    McConechy MK; Hoang LN; Chui MH; Senz J; Yang W; Rozenberg N; Mackenzie R; McAlpine JN; Huntsman DG; Clarke BA; Gilks CB; Lee CH
    J Pathol Clin Res; 2015 Jul; 1(3):173-85. PubMed ID: 27499902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
    Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
    Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
    [No Abstract]   [Full Text] [Related]  

  • 10. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma.
    Li J; Xing X; Li D; Zhang B; Mutch DG; Hagemann IS; Wang T
    Neoplasia; 2017 Feb; 19(2):100-111. PubMed ID: 28088687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
    Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
    Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
    Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
    Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin.
    Growdon WB; Roussel BN; Scialabba VL; Foster R; Dias-Santagata D; Iafrate AJ; Ellisen LW; Tambouret RH; Rueda BR; Borger DR
    Gynecol Oncol; 2011 Apr; 121(1):212-7. PubMed ID: 21168197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.
    Trento M; Munari G; Carraro V; Lanza C; Salmaso R; Pizzi S; Santoro L; Chiarelli S; Dal Santo L; Nardelli GB; Saccardi C; Nicoletto O; Baldoni A; Rugge M; Fassan M
    Int J Gynecol Pathol; 2020 Jul; 39(4):305-312. PubMed ID: 31688243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Components of Variant Profiles in Primary Vaginal Carcinosarcoma via Next-Generation Sequencing and a Literature Review.
    Kotoku R; Yanazume S; Kuroda T; Kobayashi Y; Kitazono I; Akahane T; Tanimoto A; Kobayashi H
    Int J Surg Pathol; 2022 May; 30(3):288-294. PubMed ID: 34463147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
    Tseng JH; Bisogna M; Hoang LN; Olvera N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Levine DA; Jelinic P
    Sci Rep; 2017 Jun; 7(1):3614. PubMed ID: 28620240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma.
    Osakabe M; Fukagawa D; Sato C; Sugimoto R; Uesugi N; Ishida K; Itamochi H; Sugiyama T; Sugai T
    Int J Gynecol Cancer; 2019 Feb; 29(2):277-281. PubMed ID: 30636710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.
    Schipf A; Mayr D; Kirchner T; Diebold J
    Virchows Arch; 2008 Mar; 452(3):259-68. PubMed ID: 18193277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
    Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
    BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.